GLP-1 Alternatives in 2026: Best Non-GLP-1 Weight-Loss Medications, Supplements and Natural Strategies

Last updated: October 12, 2026 | Editorial review: OneDayMD Editorial Team

GLP-1 alternatives include non-GLP-1 prescription weight-loss medicines, structured nutrition and exercise programs, behavioral treatment, and, for eligible people, metabolic and bariatric surgery. Some supplements may help fill nutritional gaps, but most products marketed as natural weight-loss drugs have not demonstrated effects comparable to prescription obesity medications.

If you are considering an alternative to Ozempic, Wegovy, Mounjaro or Zepbound, start by identifying why you want to switch. Your best option may depend on cost, side effects, injection preferences, medical history, blood sugar control, and the amount of weight you need to lose.

Key takeaway: Among established non-GLP-1 prescription options, phentermine/topiramate has demonstrated comparatively substantial weight loss in clinical evidence, but it is unsuitable for some people and requires medical supervision. Orlistat generally produces more modest results. Lifestyle treatment remains essential, while supplements marketed as "natural Ozempic" should not be assumed to work like prescription medicines.

This guide compares the leading options using clinical guidelines, regulatory information and published evidence. It is educational information, not an individualized treatment recommendation.

In this guide

• GLP-1 alternatives at a glance
• Best non-GLP-1 prescription medications
• Other medicines that may affect weight
• Supplements and natural weight-loss products
• Natural strategies that have evidence
• How to lose weight while protecting muscle
• How to choose an alternative
• Frequently asked questions

1. GLP-1 Alternatives in 2026: At a Glance

Alternative	Best suited to	Expected role in weight management	Main limitation
Phentermine/topiramate	Eligible adults who need a more effective oral option	Among the more effective established non-GLP-1 medicines	Pregnancy risk, neurological effects and cardiovascular considerations
Naltrexone/bupropion	Selected adults who may benefit from appetite and craving-related treatment	Moderate weight-loss effect in clinical trials	Contraindications involving seizures, blood pressure and opioid use
Orlistat	People seeking an intestinal fat-absorption inhibitor	Modest additional weight loss alongside dietary changes	Gastrointestinal side effects and reduced absorption of some vitamins
Phentermine alone	Selected patients eligible for short-term treatment where approved	Short-term appetite suppression	Stimulant effects and limitations on duration of use
Structured lifestyle treatment	Almost everyone seeking better weight and metabolic health	Foundational treatment and long-term weight maintenance	Requires consistent habits, support and follow-up
Metabolic surgery	People who meet clinical eligibility criteria	Potentially substantial and durable weight loss	Surgical risks and lifelong nutritional follow-up

The prescription options in this table are not approved or available in every country. Their suitability also differs according to individual risk factors and other medicines being taken.

A 2026 systematic review and network meta-analysis in The BMJ evaluated 262 randomized trials involving nearly 100,000 participants. It found that phentermine/topiramate produced an estimated 8.1 percentage-point greater reduction in body weight than lifestyle intervention alone at one year (95% confidence interval 6.5 to 9.7 percentage points). This is a pooled estimate, not a guaranteed result for an individual, and it should not be interpreted as a direct head-to-head comparison with every other medication.

Source: Nong et al., comparative effects of drugs for adults with overweight or obesity, The BMJ, 2026.

2. Best Non-GLP-1 Prescription Weight-Loss Medications

Prescription obesity medicines are generally considered for adults with obesity or for adults with overweight accompanied by relevant weight-related health problems. They are used as part of a treatment plan, not as substitutes for nutrition, physical activity and behavioral support.

For example, US guidance commonly uses a body mass index (BMI) of at least 30, or at least 27 with a weight-related condition, as a threshold for considering medication. Malaysia's 2023 adult obesity guideline uses an Asian BMI threshold of at least 27.5 with comorbidities, or at least 30 without comorbidities. Individual assessment remains necessary.

References: NIDDK prescription weight-management medicines.

2.1 Phentermine/topiramate

Best for: Selected adults who need an oral medication with a comparatively strong weight-loss effect and have no relevant contraindications.

Phentermine/topiramate combines an appetite-suppressing stimulant with topiramate, a medicine that affects neurological pathways. The combination is approved for chronic weight management in the United States under the brand name Qsymia.

Potential advantages

• Among established non-GLP-1 medicines, it has demonstrated relatively substantial average weight loss.
• It is taken orally rather than by injection.
• It may be considered when lifestyle treatment alone has not produced sufficient results.

Important risks and limitations

• It is contraindicated during pregnancy because topiramate can cause fetal harm.
• It is also contraindicated in people with glaucoma, hyperthyroidism, or certain other conditions and drug exposures specified in the prescribing information.
• Possible adverse effects include tingling sensations, changes in taste, dry mouth, constipation, sleep problems, and difficulties with memory or concentration.
• Heart rate, mood, kidney function and other individual factors may require consideration and monitoring.

This combination is not appropriate for everyone. Pregnancy prevention and testing requirements are particularly important for people who could become pregnant. Treatment should be initiated and monitored by an appropriately qualified clinician.

Source: Qsymia prescribing information, DailyMed.

2.2 Naltrexone/bupropion

Best for: Selected adults whose treatment plan may benefit from addressing appetite and food-craving pathways.

Naltrexone/bupropion is an oral combination marketed as Contrave in the United States. Naltrexone affects opioid receptors, while bupropion influences noradrenaline and dopamine pathways. Together, these actions can affect appetite regulation and food-related reward signaling.

Potential advantages

• It offers a non-GLP-1 oral treatment option.
• Some people may find its effects on appetite or cravings useful as part of a broader weight-management program.

Important risks and limitations

• It is contraindicated in uncontrolled hypertension, seizure disorders, anorexia nervosa or bulimia, and chronic opioid use, among other circumstances.
• It can increase blood pressure or heart rate and may cause nausea, headache, constipation or sleep disturbance.
• It is not suitable for people taking certain other bupropion-containing medicines or those with specific drug interactions.

Naltrexone can interfere with opioid pain medicines and opioid-containing treatments. Anyone who uses opioids or may require opioid analgesia must tell their clinician before considering this medication.

Source: Contrave prescribing information, DailyMed.

2.3 Orlistat

Best for: Adults who want an established oral treatment that works in the digestive tract rather than primarily through appetite suppression.

Orlistat inhibits gastrointestinal lipases, reducing the absorption of some fat from food. It is marketed as Xenical in prescription formulations, with lower-dose products available in some countries.

Potential advantages

• It has a different mechanism from GLP-1 medicines.
• It can provide additional weight loss when combined with an appropriate reduced-calorie diet.
• It does not act as a stimulant or directly suppress appetite through the central nervous system in the same way as some alternatives.

Important risks and limitations

• Common adverse effects include oily stools, gas with discharge, urgency and increased bowel movements.
• It can reduce absorption of fat-soluble vitamins, including vitamins A, D, E and K.
• It can interact with medicines such as warfarin, cyclosporine and levothyroxine.
• It is contraindicated in chronic malabsorption syndrome and cholestasis, among other circumstances.

A clinician or pharmacist should review other medicines before treatment. People taking orlistat may need an appropriately timed multivitamin supplement.

Source: Xenical prescribing information, DailyMed.

2.4 Phentermine alone

Best for: Selected patients who need short-term pharmacological appetite suppression and meet the relevant prescribing criteria.

Phentermine is a sympathomimetic appetite suppressant. It is distinct from the phentermine/topiramate combination and should not be assumed to have the same evidence base for long-term use.

In the United States, phentermine monotherapy is approved for short-term use. Malaysia's 2023 obesity guideline also describes its use for short-term management, generally no longer than three months and/or in a cyclical manner.

Potential adverse effects include insomnia, dry mouth, a faster heart rate, increased blood pressure and other stimulant-related effects. It may be unsuitable for people with cardiovascular disease, uncontrolled hypertension, hyperthyroidism or certain other conditions.

Phentermine should not be used as an unsupervised long-term solution or obtained from unverified online sellers.

How do these medicines compare with GLP-1 drugs?

The best non-GLP-1 option is not necessarily as effective as semaglutide or tirzepatide. The 2026 BMJ review found that several GLP-1-based treatments produced larger average reductions in body weight than most established non-GLP-1 drugs. The phentermine/topiramate combination was a notable non-GLP-1 option with a comparatively strong effect.

These estimates arise from trials with different populations, durations and treatment protocols. They do not predict exactly how much an individual will lose.

3. What About Metformin, SGLT2 Inhibitors and Other Diabetes Medicines?

Some medicines prescribed for type 2 diabetes can influence body weight, but this does not make them equivalent alternatives to approved obesity medications.

Medication class	Primary role	Typical weight effect	Important distinction
Metformin	Type 2 diabetes; selected other clinical situations	Usually weight-neutral or associated with modest weight loss	Not a like-for-like substitute for an obesity drug
SGLT2 inhibitors	Type 2 diabetes; certain heart and kidney indications	Usually modest weight loss	Selection may be driven by heart or kidney benefits, not weight alone
DPP-4 inhibitors	Type 2 diabetes	Generally weight-neutral	Not a dedicated weight-loss treatment
Sulfonylureas	Type 2 diabetes	Weight gain can occur	Can cause hypoglycemia

Metformin may be appropriate for an individual with diabetes or another relevant indication, but it should not automatically be prescribed solely because someone wants an alternative to Ozempic or Wegovy. SGLT2 inhibitors also have important benefits and risks that must be assessed for the person's underlying disease.

Source: NIDDK: Prescription Medications to Treat Overweight & Obesity.

What about metabolic and bariatric surgery?

Metabolic and bariatric surgery is not a medicine, but it is an important treatment option for some people with obesity. Procedures may be considered when a person meets clinical eligibility criteria, particularly when obesity is severe or associated with significant medical complications.

Surgery requires an individualized assessment of benefits and risks, preparation, postoperative follow-up, and long-term nutritional monitoring. It is not simply a cosmetic procedure or a universal replacement for medication.

4. GLP-1 Alternatives: Do Supplements and Natural Weight-Loss Products Work?

Many supplements are advertised as natural appetite suppressants, metabolism boosters or "natural Ozempic." The important question is not whether a product affects a biological pathway in a laboratory. It is whether well-designed human studies show meaningful, sustained weight loss and acceptable safety.

The US National Center for Complementary and Integrative Health warns that most dietary supplements marketed for rapid weight loss have not been proven safe or effective. Some products sold for slimming have also been found to contain undeclared prescription medicines or other potentially harmful ingredients.

Source: NCCIH: Weight Control.

Supplement or product	Evidence for weight loss	Potential concern	Practical conclusion
Psyllium and other dietary fibre	Useful for increasing fibre intake; weight-loss effects depend on the overall diet and intervention	Bloating and interactions with absorption of some oral medicines	Consider as a dietary support, not a substitute for medication
Protein powders	Can help meet protein needs but do not independently guarantee weight loss	Excess calories, unsuitable ingredients or inappropriate use in certain medical conditions	Convenient food support when needed
Green tea extract	Effects, where present, appear modest and are not comparable to prescription obesity treatments	Concentrated extracts have been associated with liver injury	Do not rely on extracts for meaningful weight loss
Glucomannan	Clinical trial results are inconsistent	Digestive symptoms, swallowing or obstruction risks with some formulations, and potential drug interactions	Not a proven equivalent to prescription medication
Garcinia cambogia	Conflicting evidence, with any effect likely small	Reports of liver toxicity and possible drug interactions	Benefits are uncertain and risks should not be overlooked
Berberine and multi-ingredient fat burners	Insufficient evidence to establish effects comparable to approved obesity medicines	Drug interactions, inconsistent product quality and limited long-term safety evidence	Do not treat marketing claims as proof of efficacy

Evidence reviews from the US National Institutes of Health Office of Dietary Supplements discuss the variable quality of weight-loss supplement research and potential adverse effects and interactions.

Source: NIH Office of Dietary Supplements: Dietary Supplements for Weight Loss.

Are there supplements that act like natural GLP-1 drugs?

Eating fibre-rich foods and balanced meals may influence normal digestive and appetite signals. However, it is misleading to equate these physiological responses with the effects of a tested prescription GLP-1 receptor agonist.

No supplement should be assumed to reproduce the clinically established weight-loss effects of prescription GLP-1 medicines. Be particularly cautious of products promising rapid weight loss, guaranteed appetite suppression or results identical to Ozempic without injections.

What about compounded peptides or research chemicals?

Unapproved peptides sold online or labelled "for research use only" should not be treated as safe alternatives to licensed medicines. Their identity, purity, dose consistency, sterility and clinical benefits may not have been established to the standards expected of approved medicines.

Do not inject products obtained from unverified sellers. Use prescription treatments only through appropriate medical care and check the relevant national regulator's product-registration information.

5. Natural Strategies for Weight Loss Without GLP-1 Medication

Natural weight management is not a single diet, supplement or exercise routine. It is a repeatable system designed to create an appropriate energy deficit, preserve health and make weight maintenance possible.

5.1 Use a sustainable calorie deficit

Weight loss generally requires taking in less energy than the body uses over time. The best eating pattern is one that supports this goal while providing sufficient nutrients and remaining practical for everyday life.

Useful approaches include:

• Eating more vegetables, whole fruit, legumes and other fibre-rich foods.
• Including suitable sources of protein, such as fish, eggs, tofu, beans, poultry or dairy foods.
• Choosing whole grains and less heavily processed foods more often.
• Reducing excess calories from sugar-sweetened beverages, alcohol, frequent snacks and oversized portions.
• Planning meals around hunger, preferences, budget and cultural food habits rather than following an unnecessarily restrictive diet.

No single macronutrient ratio works best for everyone. A diet that is effective for a few weeks but impossible to maintain is unlikely to be a good long-term strategy.

5.2 Prioritize protein and muscle preservation

Weight loss can involve reductions in both fat mass and lean tissue. Preserving muscle is particularly important for strength, physical function and healthy ageing.

Include protein-containing foods regularly and adjust total intake for individual requirements. People with kidney disease or other conditions that affect protein requirements should seek individualized advice before substantially increasing protein intake.

Protein supplements can be convenient when food intake is insufficient, but they are not mandatory when a balanced diet already meets nutritional needs.

5.3 Combine aerobic exercise with resistance training

Walking, cycling, swimming, dancing and similar aerobic activities can support energy expenditure and cardiovascular health. Resistance training helps maintain strength and supports muscle preservation during weight loss.

For many adults, a useful general target is at least 150 minutes of moderate-intensity aerobic activity per week plus muscle-strengthening activity on two or more days, adjusted to individual ability and medical status.

People who are inactive or have significant medical conditions may need a gradual starting plan. More activity is not always better if it causes injury, exhaustion or an unsustainable routine.

Source: US Centers for Disease Control and Prevention: Adding Physical Activity as an Adult.

5.4 Use structured behavioral support

Behavioral treatment can help people identify eating triggers, plan meals, manage portions, establish activity routines and respond to setbacks. Useful methods include keeping a food diary, monitoring weight trends, planning grocery purchases and arranging regular follow-up.

A dietitian, behavioral specialist or structured weight-management program may offer more meaningful support than repeatedly switching diets or purchasing new supplements.

5.5 Address sleep, stress and the food environment

Sleep, stress and the surrounding food environment can affect appetite, food choices and the ability to maintain healthy habits. Consider a regular sleep schedule, strategies for managing stress, and making nutritious foods easier to access.

These steps do not replace medical treatment when medication is indicated, but they can strengthen a long-term weight-management plan.

Further reading: NIDDK: Eating and Physical Activity to Lose or Maintain Weight.

6. How to Lose Weight While Protecting Muscle

Weight alone does not tell the whole story. Two people who lose the same number of kilograms may experience different changes in body fat, lean tissue, fitness, strength and metabolic health.

When choosing an alternative to GLP-1 treatment, consider a plan that includes:

• A reasonable rate of weight loss: Avoid unnecessarily aggressive calorie restriction that makes adequate nutrition difficult.
• Regular resistance training: Progressively challenge major muscle groups according to ability.
• Adequate protein and overall nutrition: Meet individual needs without assuming more supplementation is always better.
• Monitoring beyond the scale: Track strength, waist circumference, functional ability and relevant medical markers when appropriate.
• Review of weight-loss medicines: Reassess treatment if there is poor tolerability, inadequate benefit or deterioration in physical function.

These principles also matter for people who continue taking GLP-1 medicines. An alternative drug does not automatically protect muscle, and stopping a weight-loss medicine can make weight maintenance more challenging.

7. How to Choose the Best GLP-1 Alternative

The best choice depends on what you want treatment to achieve and which risks matter most in your situation.

Your situation	Options to discuss	What to consider
You want a non-GLP-1 oral obesity medicine	Phentermine/topiramate, naltrexone/bupropion or orlistat, where available and appropriate	Expected benefit, contraindications, side effects, access and cost
You want to avoid stimulant effects	Potentially orlistat or another individualized approach	Digestive effects, interactions and individual suitability
You have type 2 diabetes	A diabetes treatment plan selected for glucose control and relevant heart and kidney risks	Hypoglycemia risk, weight effects and other clinical benefits
You prefer not to use prescription weight-loss medication	Structured nutrition, exercise, behavioral support and specialist assessment when needed	Sustainability, health status, support and measurable progress
You have severe obesity or important complications	Multidisciplinary obesity care, medication and assessment for metabolic surgery when eligible	Overall risk, expected benefits and long-term follow-up
You are considering stopping a GLP-1 drug	A planned transition with the prescribing clinician	Weight regain, appetite changes and continued treatment of underlying conditions

Before changing treatment, review your weight trend, treatment response, adverse effects, current medications, blood pressure and relevant metabolic conditions with your clinician. Do not stop or replace a prescribed medicine based solely on an online article or supplement advertisement.

8. Frequently Asked Questions About GLP-1 Alternatives

What is the best alternative to GLP-1 medication for weight loss?

There is no single best choice for everyone. Among established non-GLP-1 prescription options, phentermine/topiramate has demonstrated comparatively substantial average weight loss in clinical research. Orlistat, naltrexone/bupropion and short-term phentermine have different benefits and limitations. The right option depends on medical history, contraindications, local approval and individual treatment goals.

Which non-GLP-1 medication causes the most weight loss?

Phentermine/topiramate is one of the more effective established non-GLP-1 prescription treatments for obesity. A 2026 BMJ network meta-analysis estimated that it produced about 8.1 percentage points more weight loss than lifestyle intervention alone at one year. Individual outcomes vary, and this pooled estimate is not a guaranteed result.

Is there a natural alternative to Ozempic?

No supplement has been shown to reliably reproduce the effects of prescription semaglutide. A sustainable calorie deficit, nutrient-rich eating pattern, exercise, behavioral support and adequate sleep can support weight loss, but their effects should not be represented as equivalent to a prescription GLP-1 treatment.

Does berberine work like a GLP-1 medication?

Berberine is not a GLP-1 receptor agonist and should not be treated as an equivalent substitute. Evidence supporting its use for weight loss is limited, and supplements may interact with medicines. Speak with a healthcare professional before using it, especially if you take medication for diabetes or another chronic condition.

Can metformin replace Ozempic for weight loss?

Metformin may be appropriate for type 2 diabetes and selected other clinical situations, and it may be associated with modest weight loss. It is not a direct substitute for semaglutide or another approved obesity medicine. The decision should account for the condition being treated, likely benefits and other available options.

Is orlistat a good alternative to semaglutide?

Orlistat can help with weight management by reducing intestinal fat absorption, but its average weight-loss effect is generally more modest than that of semaglutide. It also has characteristic gastrointestinal adverse effects and can reduce absorption of certain vitamins. Whether it is appropriate depends on individual needs and medical history.

Is oral Wegovy or Foundayo a non-GLP-1 alternative?

No. Oral Wegovy contains semaglutide, a GLP-1 receptor agonist. Foundayo contains orforglipron, which is also a GLP-1 receptor agonist. An oral medicine may avoid injections, but it does not necessarily avoid the GLP-1 pathway.

Sources: US FDA approval of Foundayo, April 2026; NPRA safety alert on GLP-1 and dual GLP-1/GIP receptor agonists.

Can I maintain weight loss after stopping a GLP-1 medication?

It is possible, but weight regain can occur after stopping treatment. A maintenance strategy should address appetite, nutrition, activity, behavioral support and any underlying conditions. Discuss a transition plan with the prescribing clinician before making a change.

Are weight-loss supplements safe because they are natural?

No. Natural ingredients can have side effects, interact with medicines and vary in quality. Some slimming products have been found to contain undeclared drug ingredients. Check registration where required, avoid exaggerated claims, and discuss supplements with a healthcare professional.

9. The Bottom Line

GLP-1 alternatives can play a role in evidence-based weight management, but their effects and risks differ substantially.

• For stronger non-GLP-1 prescription efficacy: phentermine/topiramate is an important option to discuss when appropriate and locally available.
• For an intestinal mechanism: orlistat may suit selected patients who can tolerate its gastrointestinal effects and follow the required precautions.
• For appetite and craving-related treatment: naltrexone/bupropion may be considered when there are no relevant contraindications.
• For natural weight management: sustainable nutrition, resistance training, aerobic activity and behavioral support remain central.
• For supplements: do not assume that "natural GLP-1" or "natural Ozempic" products offer equivalent efficacy or safety.

The objective is not simply to find a cheaper or more convenient replacement for one drug. It is to choose an appropriate long-term strategy that supports weight, metabolic health, physical function and quality of life.

Medical disclaimer: This article is for general educational purposes only and does not constitute medical advice, diagnosis or a prescription. Weight-loss medicines can cause serious adverse effects and may be contraindicated in pregnancy or certain medical conditions. Availability and approvals vary by country. Consult a qualified healthcare professional before starting, stopping or changing any medication or supplement.

Editorial transparency: OneDayMD aims to present accessible health information using published evidence and regulatory sources. This article does not replace professional medical care, and evidence may change as new clinical research becomes available.

References and Further Reading

1. Nong K, et al. Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis. The BMJ, 2026.
2. US National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity.
3. US National Institutes of Health, Office of Dietary Supplements. Dietary Supplements for Weight Loss.
4. US National Center for Complementary and Integrative Health. Weight Control.
5. NIDDK. Eating and Physical Activity to Lose or Maintain Weight.
6. DailyMed. Qsymia prescribing information.
7. DailyMed. Contrave prescribing information.
8. DailyMed. Xenical prescribing information.